IFRX - inflarx.de Operating Profitability

Public company logo of InflaRx GmbH (IFRX)

InflaRx N.V. is mitigating clinical stage risks through multidisciplinary research into anti-inflammatory agents. Its high authority in intensive care is based on the development of critical products. The projected operating margin illustrates the current resilience of the business, where the latest value is recorded as 0.00. The company's stable reputational profile is confirmed by the medical community's deep trust in its expert developments.

IFRX: InflaRx GmbH Operating Margin 07/04/2022 - 11/19/2026

Analytical breakdowns for InflaRx N.V. (IFRX)

- share price and consensus valuation forecast:
- market capitalization statistics:
Fundamental company valuation:IFRX, InflaRx GmbH
Brand item of InflaRx GmbH

To assess the fundamental stability of InflaRx N.V. (IFRX), investors must analyze the efficiency of profit generation from core operations before accounting for debt obligations and taxes. An analysis of the quarterly operating margin reveals how intensive R&D expenditures for inflammation inhibitors are leading to negative cash flow and a gradual depletion of the company's existing liquid reserves.

Competing companies

ARGX (argenx N.V.) - Operating Margin|Operating Return on Sales BioNTech Pharma BNTX|Operating Sales Margin ABVX (ABIVAX)|Operating Margin ADMA Biologics, Inc. (ADMA)|Operating Margin PTGX (protagonist-inc.com)|IMVT: Return on Sales by Operating Profit|KNSA - Operating Profitability|GRFS: Operating Profitability|ADPT (Adaptive Biotechnologies) - Operating Sales Margin|Return on Sales by Operating Profit CLDX|Operating Sales Margin AUPH|BCRX (BioCryst Pharmaceuticals) - Operating Profit Ratio|Operating Profitability Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operating Profit Rate|Pharvaris N.V. - Operating Sales Margin|Operating Profit Rate ABCL|TRML: Operating Sales Margin|PGEN (Precigen) - Return on Sales by Operating Profit|pharming.com (PHAR) - Operating Profitability|Nektar Corp (NKTR) - Operating Margin|UPB (upstreambio.com) - Operating Margin|ZBIO: Operating Profit Rate|Operating Margin IMNM|Profitability of Operations Gossamer Bio Inc|Operating Margin KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Operating Profit Margin|PVLA: Operating Sales Margin|Operating Profit Margin SVRA|RIGL: Operating Margin|Return on Sales by Operating Profit ANAB|ATXS (Astria Corp) - Operating Margin|Return on Sales by Operating Profit ENGN (enGene Bio)|Operating Margin RAPT|Profitability of Operations Aerovate Therapeutics|Operating Profitability Aclaris Therapeutics Inc. ACRS|Profitability of Operations Kyverna Therapeutics Inc. (KYTX)|TLSA - Operating Profitability|CABA: Operating Profitability|VTYX (Ventyx Biosciences, Inc.) - Operating Sales Margin|THTX - Profitability of Operations|AVTX (avalotx.com) - Operating Margin|Operating Return on Sales Eledon Pharmaceuticals Inc. ELDN|Operating Margin AGEN|CLYM (Climb Bio, Inc.) - Operating Profit Rate|Operating Profitability zurabio.com ZURA|ATYR - Operating Sales Margin|Adagene Inc - Operating Margin|ImageneBio (IMA) - Operating Sales Margin|Shattuck Therapeutics (STTK) - Operating Profitability|Operating Return on Sales Equillium Inc (EQ)|Operating Sales Margin CNTB|Return on Sales by Operating Profit IMUX (Immunic, Inc.)|Operating Profitability Atara Biotherapeutics, Inc. (ATRA)|Operating Margin X4 Pharma (XFOR)|Operating Margin ACET (adicetbio.com)|Operating Margin Celularity Inc. CELU|INMB - Operating Profitability|Operating Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Operating Sales Margin|Operating Sales Margin SAB Biotherapeutics Inc.|Operating Sales Margin AKTX|Operating Sales Margin enlivex.com (ENLV)|Operating Profitability Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operating Profitability Margin|Operating Margin EDSA (Edesa Biotech Corp)|Profitability of Operations iBio (IBIO)|CARM - Operating Profitability|XTL Biopharmaceuticals (XTLB) - Operating Sales Margin|BOLT: Operating Margin|Operating Sales Margin HCW Biologics Inc.|Operating Profitability Aptevo|Return on Sales by Operating Profit AIM (AIM ImmunoTech, Inc.)|Operating Margin ADTX|Profitability of Operations GRI Bio Corp|Operating Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Operating Return on Sales|Revelation Biosciences Corp - Operating Margin|INDP (Indaptus Therapeutics, Inc.) - Return on Sales by Operating Profit|SCNI: Operating Margin|CALI - Profitability of Operations|AFMD (Affimed N.V.) - Operating Margin|Operating Profitability ALLK|Operating Sales Margin HOOK (HOOKIPA Pharma, Inc.)|IGMS - Operating Return on Sales|Operating Profitability iTeos ITOS|Ocean Bio - Operating Profitability|TC BioPharm Ltd - Operating Margin|Operating Return on Sales thirdharmonicbio.com